Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
12/23/1993 | CA2138415A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
12/23/1993 | CA2098876A1 2'-deoxy-2',2-'difluoro(2,6,8-substituted)purine nucleosides having anti-viral and anti-cancer activity and intermediates |
12/23/1993 | CA2098875A1 2'-deoxy-2'-2'-difluoro(4-substituted pyrimidine)nucleosides having anti-viral and anti-cancer activity and intermediates |
12/22/1993 | EP0574457A1 Antiviral nucleoside combination |
12/21/1993 | US5272250 Boronated phosphoramidate compounds |
12/21/1993 | US5272068 Process for producing immunosuppressant agent L-683942 by fermentation |
12/21/1993 | CA1325423C Process for the synthesis of azido-3'-deoxy-3'-thiamidine and analogs |
12/21/1993 | CA1325395C Macrolide compound |
12/15/1993 | EP0573479A1 Chimeric tar enzyme construction for hiv therapy |
12/15/1993 | CN1079473A N-phosphinylidyne small peptide |
12/14/1993 | US5270304 Therapeutic 2-alkynyl adenosine agent for ischemic diseases of the heart or brain |
12/14/1993 | US5270163 Methods for identifying nucleic acid ligands |
12/14/1993 | CA1325209C Certain 2-substituted adenosine derivatives |
12/14/1993 | CA1325208C Antiparasitic agents |
12/14/1993 | CA1325207C Insecticides and parasiticides |
12/09/1993 | WO1993024511A1 Oligonucleotide-polyamide conjugates |
12/09/1993 | WO1993024510A1 Phosphotriester-type biologically active compounds |
12/09/1993 | WO1993024508A1 Binding competent oligomers containing 2', 5' linkages |
12/09/1993 | WO1993024507A1 Conformationally restrained oligomers containing amide or carbamate linkages for sequence-specific binding |
12/09/1993 | WO1993024505A1 Reducing inflammation by time dependent administration of oligosaccharides glycosides related to blood group determinants |
12/09/1993 | CA2118522A1 Time dependent administration of oligosaccharides glycosides related to blood group determinants having a type i or type ii core structure in reducing inflammation in a sensitizedmammal arising from exposure to an antigen |
12/08/1993 | EP0572669A1 1-B(beta)-D-Arabinofuranosyl-(E)-5-(2-halogenovinyl)-uracil-derivative |
12/08/1993 | EP0572644A1 DERIVATIVES OF 9-($g(b)-D-XYLOFURANNOSYL)ADENINE AND OF 1-($g(b)-D-XYLOFURANNOSYL)CYTOSINE, PREPARATION THEREOF AND APPLICATION IN THERAPEUTICS |
12/08/1993 | CN1079215A Morpholinyl derivatives of doxorubicin and process for their preparation |
12/07/1993 | US5268464 Process for the preparation of nucleosides |
12/07/1993 | US5268376 Containing alkoxy substitution |
12/07/1993 | US5268370 Microbial transformation product of L-679,934 |
12/02/1993 | DE4217679A1 New cyclic guanosine-3,5-phosphoro-thioate derivs. - useful as ligands in affinity chromatography or for treating e.g. thromboses,. asthma, hypertonia or arteriosclerosis |
12/01/1993 | EP0571474A1 Orthomolecular method of treating sickle cell disease |
11/30/1993 | US5266692 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
11/25/1993 | WO1993023569A1 Method and reagent for inhibiting viral replication |
11/25/1993 | WO1993023418A1 Purine derivatives |
11/25/1993 | WO1993023417A1 Novel adenosine derivatives |
11/25/1993 | WO1993023416A1 Chemical synthesis of 2',3'-dideoxynucleoside 5'-triphosphates |
11/25/1993 | WO1993023415A1 CHEMICAL SYNTHESIS OF 2',3'-DIDEOXYNUCLEOSIDE 5'-(α-THIO) TRIPHOSPHATES |
11/25/1993 | WO1993023414A1 A process for the preparation of ribonucleotide reductase inhibitors |
11/25/1993 | WO1993023413A1 Synthesis of nucleotide monomers |
11/25/1993 | WO1993023058A1 Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia |
11/25/1993 | WO1993023056A1 Preventive or therapeutic agent for infectious diseases containing mizoribine as active ingredient |
11/25/1993 | WO1993023031A1 Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response |
11/25/1993 | WO1993017651A3 Antiviral nucleoside analogues, their production and use |
11/25/1993 | CA2135646A1 Method and reagent for inhibiting viral replication |
11/25/1993 | CA2135498A1 Synthesis of nucleotide monomers |
11/25/1993 | CA2113547A1 Purine derivatives |
11/25/1993 | CA2113546A1 Novel adenosine derivatives |
11/24/1993 | EP0571087A1 Cleavable phosphoramidites |
11/24/1993 | EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
11/24/1993 | EP0570514A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom |
11/24/1993 | CN1022834C Macrolide compounds, their prepn. and use |
11/23/1993 | US5264564 Oligonucleotide analogs with novel linkages |
11/23/1993 | US5264562 Oligonucleotide analogs with novel linkages |
11/23/1993 | US5264561 Method of manufacturing 2',3'-dideoxy-2',3'-didehydronucleosides |
11/23/1993 | US5264431 Inhibitors for proteinkinase C |
11/18/1993 | EP0430987B1 An amplification assay for hydrolase enzymes |
11/16/1993 | US5262531 Reaction of adenine with alkali metal alcoholate or alkali metal hydroxide to form salt and reaction with 1-chloro-2-deoxy pentofuranose with protective groups |
11/16/1993 | US5262425 α-mannosidase inhibitors |
11/16/1993 | US5262400 Antiparasitic and anthelmintic |
11/11/1993 | WO1993022328A1 Adenosine derivatives having a2 agonist activity |
11/11/1993 | WO1993022327A1 2'-methylidenenucleoside compound and pharmaceutical use thereof |
11/11/1993 | WO1993022326A1 Protecting groups useful in oligonucleotide synthesis |
11/11/1993 | WO1993022325A1 Immunoassay for 3', 5' cyclic adenosine monophosphate |
11/11/1993 | WO1993022307A1 Avermectin difluoro derivatives |
11/11/1993 | CA2134067A1 Adenosine derivatives having a2 agonist activity |
11/10/1993 | EP0569337A1 Heteroatoms-containing tricyclic compounds |
11/10/1993 | EP0568946A1 Compound TAN-1607A, its derivatives, their production, and use thereof |
11/10/1993 | EP0568553A1 Bridged cyclic ketal derivatives |
11/10/1993 | CN1022688C Fluorocytidine derivatives |
11/10/1993 | CN1022687C Process for prepn. of glycoside derivatives |
11/09/1993 | US5260433 Saccharide specific binding system labeled nucleotides |
11/09/1993 | US5260427 Nucleosidylphosphite-borane compounds and method of making the same |
11/09/1993 | CA2095782A1 Compound tan-1607a, its derivatives, their production and use thereof |
11/09/1993 | CA1324128C 2', 2'-difluoronucleosides |
11/03/1993 | EP0567841A2 Fluorescently marked compounds, their preparation and use |
11/03/1993 | EP0505388A4 Improved one piece pouring spout sealed to innermost and outermost surfaces of moisture impervious carton |
10/28/1993 | WO1993021201A1 Composition and method for utilizing nucleosides as ion carriers |
10/28/1993 | WO1993020825A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent |
10/28/1993 | WO1993020805A1 Chemical prevention or reversal of cataract by phase separation inhibitors |
10/28/1993 | CA2133727A1 Chemical prevention or reversal of cataract by phase separation inhibitors |
10/27/1993 | EP0567094A2 Hydrazoadenosines |
10/27/1993 | EP0566625A1 Method for extraction of intracellular components. |
10/27/1993 | EP0432183B1 New citydin-5'-diphosphate alkanols and glycerols, a process for preparing them and their use |
10/27/1993 | EP0271552B1 Derivatives of all-trans- and 13-cis retinoic acid and methods for preparing same |
10/27/1993 | EP0222889B1 Cytidine analogs |
10/27/1993 | EP0191824B1 Encapsulation of antineoplastic agents in liposomes |
10/27/1993 | EP0190315B1 Dehydrated liposomes |
10/27/1993 | CN1022570C Process for preparing antiviral compounds |
10/26/1993 | US5256689 Cholesterol lowering compounds |
10/26/1993 | US5256650 Hypotensive, antispasmodic agents; sedatives; vasodilation |
10/26/1993 | US5256646 Antiviral antibiotic BU-4224V |
10/26/1993 | US5256641 Covalent polar lipid-peptide conjugates for immunological targeting |
10/20/1993 | EP0566459A1 Reagent and catalytic process for cleaving protected functional groups |
10/20/1993 | EP0566162A1 2'-Methylidenepyrimidine Nucleoside Compounds, their use and method for production thereof |
10/20/1993 | EP0565646A1 Nucleosides and oligonucleosides with a phosphate-free internucleoside backbone and process for preparing the same |
10/20/1993 | EP0338042B1 Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil |
10/19/1993 | US5254562 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
10/19/1993 | US5254539 Method of treating HIV with 2',3'-dideoxyinosine |
10/16/1993 | CA2093989A1 Reagent and catalytic process for clearing a protected function |
10/14/1993 | WO1993019762A1 Compositions for the treatment of infection and disease caused by hepatitis b virus (hbv) |
10/14/1993 | WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
10/13/1993 | EP0565412A1 Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections |